When will the Infrastructure be In Place for Continuous to Overtake Batch?

Time: 3:40 pm
day: Day Two AM

Details:

• Evaluation of currently available external manufacturing infrastructure for small and large molecules, is this ahead, behind or inline with in-house?

• What needs to be overcome for continuous to overtake batch as the preferred method of production cross the industry?

• How to adapt continuous equipment suites so they are as flexible as batch sets ups? Which is particularly important for CMO models?

• Is modularization the answer to enable adaptable process flow? Contrasting a hybrid approach for integrated continuous manufacturing vs end-to-end

• How can CM be leveraged to speed up development into commercial production? When is the right time to go continuous in the life cycle of the drug?

Speakers: